| Literature DB >> 28547740 |
Ryusuke Saito1, Hiroyuki Tahara2, Seiichi Shimizu1, Masahiro Ohira1, Kentaro Ide1, Kohei Ishiyama1, Tsuyoshi Kobayashi1, Hideki Ohdan1.
Abstract
BACKGROUND: Despite the improvements of surgical techniques and postoperative management of patients with liver transplantation, biliary complications are one of the most common and important adverse events. We present a first case of choledochoduodenostomy using magnetic compression following a massive resection of the small intestine due to strangulated ileus after living donor liver transplantation. CASEEntities:
Keywords: Choledochoduodenostomy; Living donor liver transplantation; Magnetic compression anastomosis; Primary sclerosing cholangitis; Short bowel syndrome
Year: 2017 PMID: 28547740 PMCID: PMC5445037 DOI: 10.1186/s40792-017-0349-4
Source DB: PubMed Journal: Surg Case Rep ISSN: 2198-7793
Fig. 1Schema of anatomical relationship between the biliary duct and duodenum a before magnetic anastomosis and b after anastomosis. a External drainage tube was placed in the biliary cavity and b PTBD tube was placed over the anastomosis
Fig. 2a Computed tomography showed the bulbus duodeni (white arrow) and biliary duct (black arrow) come in contact with each other. b PTBD tube was placed into B3. c The parent magnet was inserted from PTBD tube, and daughter magnet was placed by gastrointestinal endoscopy. d The parent and daughter magnets connected sandwiching the biliary wall and duodenal wall
Fig. 3The kinetics of the hepatobiliary enzymes and nutritional indexes
Fig. 4Endoscopy showed no stenosis after removal of the PTBD stent
Outcomes of magnetic compression anastomosis for biliary stricture after liver transplantation
| Author [references] | Age | Gender | Disease | Operation | Type of intervention | Duration from LT (months) | Period until removal of magnets (days) | Duration of internal catheter (weeks) | Follow-up period (months) | Reintervention |
|---|---|---|---|---|---|---|---|---|---|---|
| Mimuro et al. [ | 1 | F | Fulminant hepatitis | LDLT of left lobe with R-Y | CJS | 6 | 12 | 8 | 54 | None |
| 57 | M | LC with HCC | LDLT of right lobe with R-Y | CJS | 7 | 12 | 8 | 6 | Balloon dilatation | |
| Okajima et al. [ | 44 | F | Fulminant hepatitis | LDLT of right lobe with D-D | CCS | 12 | 42 | 12 | 15 | None |
| Akita et al. [ | 34 | F | N/A | LDLT of right lobe with D-D | CCS | 0 | 21 | None | N/A | N/A |
| Mita et al. [ | 0.5 | F | Fulminant hepatitis | LDLT of lateral segment with R-Y | CJS | 1.5 | 12 | N/A | 73.4 | None |
| 59 | F | LC | LDLT of left lobe with R-Y | CJS | 5 | 25 | N/A | 62.2 | ESWL | |
| Matsuno et al. [ | 53 | M | N/A | LDLT of right lobe with D-D | CCS | N/A | 10 | 4.3 | 36 | None |
| Itoi et al. [ | 60 | M | N/A | LDLT of right lobe with D-D | CCS | 18 | 9 | 24 | 2 | None |
| Jang et al. [ | 63 | F | LC with HCC (HBV) | LDLT with D-D | CCS | 71 | 42 | 83 | 19.4 | None |
| 49 | M | LC with HCC (HBV) | LDLT with D-D | CCS | 6 | 26 | 70 | 16.4 | None | |
| 54 | M | LC with HCC (HBV) | LDLT with D-D | CCS | 55 | 18 | 49 | 11.4 | None | |
| 64 | F | LC with HCC (HBV) | LDLT with D-D | CCS | 71 | 71 | 14 | 3.3 | Balloon dilatation | |
| 54 | M | LC (HBV) | LDLT with D-D | CCS | 15 | 102 | 26.7 | 9.5 | None | |
| 48 | M | LC with HCC (HBV) | LDLT with D-D | CCS | 13 | 102 | 25.7 | 8.8 | None | |
| 63 | F | HF (drug-induced) | LDLT with D-D | Failure | 107 | – | – | – | – | |
| 33 | M | HF (HAV) | LDLT with D-D | CCS | 5 | 33 | 26.7 | 10.4 | None | |
| 61 | M | LC with HCC (HBV) | LDLT with D-D | CCS | 4 | 14 | 25.4 | 96.9 | None | |
| 54 | M | LC with HCC (HBV) | LDLT with D-D | CCS | 9 | 181 | 7.3 | 4.9 | None | |
| 52 | M | LC (HBV) | LDLT with D-D | CCS | 1 | 153 | indwelling | N/A | None | |
| 51 | M | LC (HBV) | LDLT with D-D | Failure | 5 | – | – | – | – | |
| Perez-Miranda et al. [ | 53 | M | N/A | Orthotopic LT with D-D | CCS | 36 | 10 | Indwelling | N/A | None |
| Present case | 54 | F | LC (PSC) | LDLT of left lobe with R-Y | CDS | 60 | 25 | 44 | 4 | None |
CCS choledochocholedochostomy, CDS choledochoduodenostomy, CJS choledochojejunostomy, ESWL extracorporeal shock wave lithotripsy, D-D duct-to-duct anastomosis, F female, HAV hepatitis type A virus, HBV hepatitis type B virus, HCC hepatocellular carcinoma, HF hepatic failure, LC liver cirrhosis, LDLT living donor liver transplantation, LT liver transplantation, M male, N/A not addressed, PSC primary sclerosing cholangitis, R-Y Roux-en Y anastomosis